-
2
-
-
0032437504
-
Joint British Recommendations on prevention of coronary heart disease in clinical practice
-
Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R. Joint British Recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80 S2: 1–29.
-
(1998)
Heart
, vol.80
, Issue.S2
, pp. 1-29
-
-
Wood, D.1
Durrington, P.2
Poulter, N.3
McInnes, G.4
Rees, A.5
Wray, R.6
-
3
-
-
0032874699
-
Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
-
Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569–592.
-
(1999)
J Hum Hypertens
, vol.13
, pp. 569-592
-
-
Ramsay, L.E.1
Williams, B.2
Johnston, G.D.3
MacGregor, G.A.4
Poston, L.5
Potter, J.F.6
-
4
-
-
0025959101
-
An updated coronary risk profile: A statement for health professionals
-
Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: A statement for health professionals. Circulation 1991; 83: 356–362.
-
(1991)
Circulation
, vol.83
, pp. 356-362
-
-
Anderson, K.M.1
Wilson, P.W.F.2
Odell, P.M.3
Kannel, W.B.4
-
5
-
-
0034635906
-
Updated New Zealand cardiovascular disease risk-benefit prediction guide
-
Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000; 320: 709–710.
-
(2000)
BMJ
, vol.320
, pp. 709-710
-
-
Jackson, R.1
-
6
-
-
0034635863
-
Coronary and cardiovascular risk estimation for primary prevention: Validation of new Sheffield table in the 1995 Scottish health survey population
-
Wallis EJ. Coronary and cardiovascular risk estimation for primary prevention: Validation of new Sheffield table in the 1995 Scottish health survey population. BMJ 2000; 320: 671–676.
-
(2000)
BMJ
, vol.320
, pp. 671-676
-
-
Wallis, E.J.1
-
7
-
-
0003531808
-
-
London: British Medical Association; March
-
British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary 41. London: British Medical Association; March 2001.
-
(2001)
British National Formulary 41
-
-
-
9
-
-
0032987038
-
Indications for cholesterol-lowering medication: Comparison of risk-assessment methods
-
Durrington PN, Prais H, France M, Crowley V, Khan J, Morgan J. Indications for cholesterol-lowering medication: Comparison of risk-assessment methods. Lancet 1999; 353: 278–281.
-
(1999)
Lancet
, vol.353
, pp. 278-281
-
-
Durrington, P.N.1
Prais, H.2
France, M.3
Crowley, V.4
Khan, J.5
Morgan, J.6
-
12
-
-
0031753938
-
Ischemic heart disease and stroke mortality in African-American, Hispanic and non-Hispanic white men and women, 1985–1991
-
Karter AJ, Gazzaniga JM, Cohen RD, Casper ML, Davis BD, Kaplan GA. Ischemic heart disease and stroke mortality in African-American, Hispanic and non-Hispanic white men and women, 1985–1991. West J Med 1998; 169: 139–145.
-
(1998)
West J Med
, vol.169
, pp. 139-145
-
-
Karter, A.J.1
Gazzaniga, J.M.2
Cohen, R.D.3
Casper, M.L.4
Davis, B.D.5
Kaplan, G.A.6
-
13
-
-
0032996943
-
Is the Framingham risk function valid for Northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men
-
Haq IU, Ramsay LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for Northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 40–46.
-
(1999)
Heart
, vol.81
, pp. 40-46
-
-
Haq, I.U.1
Ramsay, L.E.2
Yeo, W.W.3
Jackson, P.R.4
Wallis, E.J.5
-
14
-
-
0030710191
-
Prediction of coronary heart disease mortality in Busselton, Western Australia; an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores
-
Knuiman MW, Vu H.T.V. Prediction of coronary heart disease mortality in Busselton, Western Australia; an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health 1997; 51: 515–519.
-
(1997)
J Epidemiol Community Health
, vol.51
, pp. 515-519
-
-
Knuiman, M.W.1
Vu, H.T.V.2
-
15
-
-
0032513878
-
Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial
-
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
|